p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Jurnal Biologi Tropis
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Antibacterial Activity Test of Sumbawa White Honey against Escherichia coli ATCC 25922 Hulfifa, Lale Nandita; Rosyunita, Rosyunita; Wardoyo, Eustachius Hagni; Hasbi, Nurmi; Rahim, Adelia Riezka; Arnawati, Ida Ayu; Alamsyah, Abiel Dwi Cahya Firdaus; Vaidika, I Komang Satya; Hazaa, Saskia Safarina
Jurnal Biologi Tropis Vol. 24 No. 3 (2024): July - September
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v24i3.7407

Abstract

Due to their high mortality and morbidity rates, E. coli infections are a serious issue. Antimicrobial Resistance (AMR) is a result of this indiscriminate antibiotic use. One approach to address this issue is to utilize natural antimicrobials such as Sumbawa white honey. Sumbawa white honey contains antibacterial components like glucose and fructose (80%), water (17%), polyphenols, and hydrogen peroxide. This study aimed to analyze the antibacterial activity of white honey from Sumbawa against E. coli ATCC 25922. The research method employed was a laboratory experiment using a post test only control group design. Antibacterial testing was conducted using disc diffusion at concentrations of 25%, 75%, and 100%, with chloramphenicol as positive control and DMSO as negative control, and honey processing involved dilution. Antibacterial tests were repeated five times  and antibacterial activity was observed based on the diameter of inhibition zones around the disc. The outcomes showed that there was a restraint zone at 100 percent grouping of honey, to be specific 0.90 mm, while at 25% and 75% fixations there were no hindrance zones. According to the findings of this study, white honey from Sumbawa has a low antibacterial activity (0.90 mm), but this activity is ineffective against E. coli ATCC 25922. Further identification of the chemical components in Sumbawa white honey that are primarily responsible its antibacterial effect.
Necrotizing Enterocolitis: Stem Cell as Future Potential Therapy Syafitri, Bq. Annisa Salmaadani; Manafe, Carolina Janicca Winda; Hulfifa, Lale Nandita; Aziri, Zirly Vera; Afifah, Fiza; Wahyudi, Syahla Marsellita; Musyarof, Disa Fadil
Jurnal Biologi Tropis Vol. 24 No. 4 (2024): Oktober - Desember
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v24i4.7529

Abstract

Necrotizing enterocolitis (NEC) is an inflammatory bowel condition in infants and considered as one of the leading causes of death in infants, especially premature infants. The high mortality rate due to NEC in recent decades has become a problem because there is no current therapy that can optimally treat NEC. Currently, NEC is treated using Bell's Staging as a guide and surgery is a common procedure, especially if necrosis has occurred. However, complications arising from surgery not only reduce the patient's quality of life but can also result in death. Therefore, it is necessary to find new therapy in order to treat NEC effectively and minimize the possibility of side effects in NEC patients. Stem cells are known for their regenerative abilities which is potential to overcome tissue damage due to excessive inflammation in NEC. Previous studies also show that stem cells have become new therapy to treat other intestinal diseases which have similar features with NEC. This study aims to explain mainly on stem cells’s promising mechanism of action in treating NEC. The method used for this study is a literature review design by selecting and reviewing relevant previous literature using databases such as Google Scholar, PubMed and Science Direct. This paper summarizes pathophysiology, clinical manifestation, current therapy and mechanism of action of stem cells and their derivatives as future potential therapy for NEC. Based on evidence found, stem cells and their derivatives are potential to be used as NEC therapy in the future. However, the data obtained is not sufficient to support its use in humans. Given the urgency in finding an effective NEC management and the potency of stem cells, further research is needed to support the use of stem cells as NEC therapy.